Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-27 @ 2:23 AM
Study NCT ID:
NCT01352793
Status:
COMPLETED
Last Update Posted:
2015-03-11
First Post:
2011-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Meningitis, Meningococcal | View |